Prestige News

Total 79
Number Thumbnail Title Author Date Votes Views
69 Prestige Biopharma Positions PBP1710 as Its Next-Generation Growth Driver
김** | 2026.08.11 | Votes 0 | Views 2846
김** 2026.08.11 0 2846
68 Prestige Biopharma CEO Soyeon Park Purchases Approximately 70,000 Additional Shares, Bringing Total Purchases to 161,765 Shares
김** | 2026.08.04 | Votes 0 | Views 2611
김** 2026.08.04 0 2611
67 Prestige Biopharma IDC Publishes Preclinical Efficacy Results of IDC007 in International Academic Journal
김** | 2026.07.16 | Votes 0 | Views 3662
김** 2026.07.16 0 3662
66 Prestige Biopharma Unveils Follow-up Clinical Development Strategy for Pancreatic Cancer Drug Candidate PBP1510 at ESMO GI
김** | 2026.07.09 | Votes 0 | Views 4658
김** 2026.07.09 0 4658
65 Prestige Biopharma IDC Publishes Preclinical Results for Bispecific Antibody IDC007, Targeting Immunotherapy Side Effects
김** | 2026.07.07 | Votes 0 | Views 4132
김** 2026.07.07 0 4132
64 Prestige Biopharma Enters Strategic MOU with Charles River , a Global Contract Research Organization
김** | 2026.07.02 | Votes 0 | Views 5037
김** 2026.07.02 0 5037
63 Prestige Biopharma to Present Clinical Development Strategy for Pancreatic Cancer Candidate at ESMO GI 2026
김** | 2026.06.30 | Votes 0 | Views 5058
김** 2026.06.30 0 5058
62 Prestige Biopharma to Participate in BIO USA 2026, Targeting Global Market Expansion
김** | 2026.06.16 | Votes 0 | Views 5204
김** 2026.06.16 0 5204
61 Prestige Biopharma IDC Selected for Ministry of Health and Welfare’s Advanced Biopharma Convergence Talent Development Program
김** | 2026.06.08 | Votes 0 | Views 3632
김** 2026.06.08 0 3632
60 Prestige Biopharma Outlines Phase 2a Clinical Development Roadmap for Pancreatic Cancer Therapy PBP1510
김** | 2026.06.01 | Votes 0 | Views 3952
김** 2026.06.01 0 3952